CTRI/2023/02/049618
Not yet recruiting
未知
A pilot trial to assess the effect of ultrafiltration profiling on myocardial injury markers in patients on maintenance hemodialysis
Dr Namrata Rao S0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: N186- End stage renal disease
- Sponsor
- Dr Namrata Rao S
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients \> 18 years of age, on maintenance hemodialysis \> 3 months with UF removal rates of \> 13 ml/kg/hour in \> 3 occasions in the screening month and not receiving any UF profiling in the screening month
Exclusion Criteria
- •Active infection, hospitalization during screening month, unstable angina, NYHA Class IV heart failure, noncompliance to dialysis schedules, any requirement of \> 4 dialysis sessions/week in the screening month, receiving UF and/or sodium profiling in routine HD prescription in the screening month, and intradialytic hypotension \> 1 episode requiring session or ultrafiltration termination in the screening month
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Investigating the effects of modified ultrafiltration on rotational thromboelastometry (ROTEM) and inflammatory cytokine response in patients under cardiopulmonary bypass surgerycoronary artery disease.Atherosclerotic heart diseaseIRCT2017042127617N3Vice Chancellor for Research, Iran University of Medical Sciences60
Terminated
Not Applicable
Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus DiureticsAcute Decompensated Heart FailureNCT01457053University of Cincinnati4
Withdrawn
Not Applicable
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid OverloadLeukemiaNCT01508260M.D. Anderson Cancer Center
Completed
Not Applicable
ltrafiltration (UF) Effectiveness on intradialytic hypertension (IDH)Kidney DiseasePACTR202001714181321ephrology department24
Not yet recruiting
Not Applicable
A study to find the role of N acetyl cysteine given intraductally in the submandibular gland on reducing radiotherapy related side effects such as swallowing difficulties and voice changes in patients with oropharyngeal cancer undergoing radiotherapy.Health Condition 1: C10- Malignant neoplasm of oropharynxCTRI/2020/10/028521ENT Department